Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus outer capsid glycoprotein VP7 is a major structural protein of the rotavirus virion, forming the outer shell of the triple-layered viral particle. It functions as a calcium-binding protein that plays a critical role in viral attachment and entry into host enterocytes, interacting with cell surface receptors after initial binding by the VP4 spike protein. VP7 is the primary determinant of the G (glycoprotein) serotype classification of rotaviruses, with the G2 serotype being one of the most prevalent causes of severe diarrheal disease in infants and young children worldwide. As a major target of neutralizing antibodies, the G2 antigen is incorporated into several live-attenuated and reassortant rotavirus vaccines, such as the pentavalent vaccine RotaTeq. Immunization with these vaccines elicits homotypic and heterotypic immune responses, protecting against severe rotavirus-induced gastroenteritis. However, the target faces challenges from antigenic drift, where specific amino acid substitutions in the antigenic regions of VP7 (such as the D96N mutation) can lead to vaccine escape and altered serotype prevalence.
Active immunization by presenting the G2 VP7 antigen to the host immune system, eliciting the production of neutralizing antibodies and memory B cells that target the outer capsid of the virus, thereby preventing viral attachment, entry, and subsequent replication in host enterocytes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus outer capsid glycoprotein VP7 (VP7).